Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Immunosuppressant Drug Labels Updated To Reflect Infection Risk

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA requires the labels for a handful of immunosuppressants used in kidney transplantation to reflect risk of infection, including activation of latent viral infections.

You may also be interested in...

Increased Mortality In Rapamune Liver Transplant Study Sparks FDA Alert

Wyeth notified the agency about increased mortality in the sirolimus arm of a comparative study and is seeking a safety update for the immunosuppressant’s labeling, the company said.

CellCept, Myfortic Labeling Get PML Warning

Labeling update for transplant drugs follows postmarketing reports of progressive multifocal leukoencephalopathy.

IFRA Hosts Capitol Hill Scent Experience In Timeout From Policy Concerns

The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts